These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34839148)

  • 1. Dysregulated CD40 and CD40 ligand expression in anti-N-methyl-d-aspartate receptor encephalitis.
    Ma X; Chen C; Fang L; Zhong X; Chang Y; Li R; Wang Y; Hu X; Qiu W; Shu Y
    J Neuroimmunol; 2022 Jan; 362():577762. PubMed ID: 34839148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid pentraxin 3 and CD40 ligand in anti-N-menthyl-d-aspartate receptor encephalitis.
    Liu B; Ai P; Zheng D; Jiang Y; Liu X; Pan S; Wang H
    J Neuroimmunol; 2018 Feb; 315():40-44. PubMed ID: 29306404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
    Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
    Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD40 and CD40L on peripheral blood mononuclear cells in patients with condyloma acuminatum.
    Liu D; Jiang W; Chen X; Chen Y; Yang D
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):378-9. PubMed ID: 16961300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients.
    Jiang XY; Lei S; Zhang L; Liu X; Lin MT; Blumcke I; Piao YS; Zhou D; Li JM
    Acta Neuropathol Commun; 2020 Aug; 8(1):130. PubMed ID: 32771066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Japanese Encephalitis Virus-Induced Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Report and Review of Literature.
    Tian M; Li J; Lei W; Shu X
    Neuropediatrics; 2019 Apr; 50(2):111-115. PubMed ID: 30620950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis.
    Ramirez SH; Fan S; Dykstra H; Reichenbach N; Del Valle L; Potula R; Phipps RP; Maggirwar SB; Persidsky Y
    J Neurosci; 2010 Jul; 30(28):9454-64. PubMed ID: 20631174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD40 and CD40 ligand among cell populations within rheumatoid synovial compartment.
    Liu MF; Chao SC; Wang CR; Lei HY
    Autoimmunity; 2001; 34(2):107-13. PubMed ID: 11905840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic basis of co-stimulatory CD40-CD40L ligation mediated regulation of immune responses in cancer and autoimmune disorders.
    Chand Dakal T; Dhabhai B; Agarwal D; Gupta R; Nagda G; Meena AR; Dhakar R; Menon A; Mathur R; Mona ; Yadav V; Sharma A
    Immunobiology; 2020 Mar; 225(2):151899. PubMed ID: 31899051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the CD40/CD40L role in the sustenance of alloreactive antibody production.
    Shoker AS; Lun ZR; Choudry R; Saxena A
    Transpl Immunol; 2001 Feb; 8(4):219-28. PubMed ID: 11316064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood CD40-CD40L expression in human breast cancer.
    Pan W; Gong J; Yang C; Feng R; Guo F; Sun Y; Chen H
    Ir J Med Sci; 2013 Dec; 182(4):719-21. PubMed ID: 23456134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond.
    Karnell JL; Rieder SA; Ettinger R; Kolbeck R
    Adv Drug Deliv Rev; 2019 Feb; 141():92-103. PubMed ID: 30552917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of CD40--CD40 ligand system in patients with diabetes mellitus.
    Jinchuan Y; Zonggui W; Jinming C; Li L; Xiantao K
    Clin Chim Acta; 2004 Jan; 339(1-2):85-90. PubMed ID: 14687897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.
    Danese S; Sans M; Scaldaferri F; Sgambato A; Rutella S; Cittadini A; Piqué JM; Panes J; Katz JA; Gasbarrini A; Fiocchi C
    J Immunol; 2006 Feb; 176(4):2617-24. PubMed ID: 16456024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel qEEG Biomarker to Distinguish Anti-NMDAR Encephalitis From Other Types of Autoimmune Encephalitis.
    Mizoguchi T; Hara M; Hirose S; Nakajima H
    Front Immunol; 2022; 13():845272. PubMed ID: 35242143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis.
    Tanaka H; Yang GX; Iwakoshi N; Knechtle SJ; Kawata K; Tsuneyama K; Leung P; Coppel RL; Ansari AA; Joh T; Bowlus C; Gershwin ME
    Clin Exp Immunol; 2013 Dec; 174(3):364-71. PubMed ID: 23981074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid Metabolism in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
    Shu Y; Qin B; Xu Y; Sun X; Chen Z; Wang J; Peng L; Qiu W; Lu Z; Wu A
    Neuroimmunomodulation; 2017; 24(4-5):256-263. PubMed ID: 29393234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Genetic Variation in CD40 and CD40L: Relationship with mRNA Relative Expression and Soluble Proteins in Acute Coronary Syndrome.
    Martínez-Fernández DE; Padilla-Gutiérrez JR; Casillas-Muñoz F; Valdés-Alvarado E; Parra-Reyna B; Aceves-Ramírez M; Muñoz-Valle JF; Zalapa Flores U; Chávez Herrera JC; Valle Y
    J Immunol Res; 2019; 2019():8063983. PubMed ID: 31183392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis.
    Ramanujam M; Steffgen J; Visvanathan S; Mohan C; Fine JS; Putterman C
    Autoimmun Rev; 2020 Nov; 19(11):102668. PubMed ID: 32942031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40L-Dependent Pathway Is Active at Various Stages of Rheumatoid Arthritis Disease Progression.
    Guo Y; Walsh AM; Fearon U; Smith MD; Wechalekar MD; Yin X; Cole S; Orr C; McGarry T; Canavan M; Kelly S; Lin TA; Liu X; Proudman SM; Veale DJ; Pitzalis C; Nagpal S
    J Immunol; 2017 Jun; 198(11):4490-4501. PubMed ID: 28455435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.